首页|期刊导航|心脑血管病防治|外周血内皮细胞特异性分子-1、鸢尾素与急性冠状动脉综合征患者PCI术后慢血流或无复流的相关性

外周血内皮细胞特异性分子-1、鸢尾素与急性冠状动脉综合征患者PCI术后慢血流或无复流的相关性OA

Correlation between peripheral blood endothelial cell specific molecule-1,Irisin,and slow-flow/no-reflow after PCI in patients with acute coronary syndrome

中文摘要英文摘要

目的 探讨外周血内皮细胞特异性分子-1(Endocan)、鸢尾素(Irisin)与急性冠状动脉综合征(ACS)患者经皮冠状动脉介入治疗(PCI)术后慢血流或无复流(SF/NR)的关系.方法 选取2021年1月至2024年3月在吉林市化工医院行PCI术的ACS患者215例(ACS组)和同期114例体检健康志愿者(对照组),ACS患者根据PCI术后血流灌注情况分为SF/NR组(144例)与正常血流组(71 例).检测外周血Endocan、Irisin水平.多因素Logistic回归分析ACS患者PCI术后SF/NR影响因素,受试者工作特征(ROC)曲线分析外周血Endocan、Irisin水平对ACS患者PCI术后SF/NR的预测价值.结果 与对照组比较,ACS组外周血Endocan水平升高,Irisin水平降低(t=23.545、-15.047,均P<0.01).215 例ACS患者PCI术后SF/NR发生率为 33.02%(71/215).与正常血流组比较,SF/NR组外周血Endocan水平升高,Irisin水平降低(t=7.953、-8.086,均P<0.01).ACS患者PCI术后SF/NR的危险因素为低密度脂蛋白胆固醇升高和Endocan升高[OR(95%CI)=1.234(1.058~1.439)、1.323(1.200~1.458)],保护因素为Irisin升高[OR(95%CI)=0.969(0.957~0.980)].外周血Endocan、Irisin水平联合预测ACS患者PCI术后SF/NR的曲线下面积为0.896(95%CI=0.847~0.933),大于单一指标预测(Z=4.146、4.167,均P<0.01).结论 外周血Endocan水平升高和Irisin水平降低与ACS患者PCI术后SF/NR密切相关,外周血Endocan、Irisin水平联合预测ACS患者PCI术后SF/NR的价值较高.

Objective To investigate the relationship between peripheral blood endothelial cell specific molecule-1(Endocan),Irisin,and the occurrence of slow-flow/no-reflow(SF/NR)after percutaneous coronary intervention(PCI)in patients with acute coronary syndrome(ACS).Methods A total of 215 ACS patients who underwent PCI in Jilin City Hospital of Chemical Industry from January 2021 to March 2024 were selected as the ACS group,and 114 healthy volunteers during the same period were recruited as the control group.ACS patients were further divided into an SF/NR group(71 cases)and a normal blood flow group(144 cases)according to the blood perfusion after PCI.The levels of Endocan and Irisin in peripheral blood were detected.The influencing factors for SF/NR in ACS patients after PCI were analyzed by multivariate Logistic regression,and the predictive value of peripheral blood levels of Endocan and Irisin for SF/NR in ACS patients after PCI were analyzed by receiver operating characteristic(ROC)curve.Results Compared with the control group,the level of Endocan in peripheral blood in the ACS group was significantly higher,and the level of Irisin was significantly lower(t=23.545,-15.047;P<0.01).Among the 215 ACS patients,the incidence of SF/NR after PCI was 33.02%(71/215).Compared to the normal blood flow group,the SF/NR group demonstrated significantly elevated Endocan level and reduced Irisin level in peripheral blood(t=7.953,-8.086;P<0.01).The risk factors for SF/NR in ACS patients after PCI were elevated low density lipoprotein cholesterol[OR(95%CI)=1.234(1.058-1.439)]and elevated Endocan[OR(95%CI)=1.323(1.200-1.458)],while the protective factor was elevated Irisin[OR(95%CI)=0.969(0.957-0.980)].The area under the curve for the prediction of SF/NR in ACS patients after PCI by combination of peripheral blood Endocan and Irisin levels was 0.896(95%CI=0.847-0.933),which was significantly greater than that of single index prediction(Z=4.146,4.167;P<0.01).Conclusion Elevated peripheral blood Endocan and decreased Irisin levels are closely related to SF/NR after PCI in ACS patients.The combination of peripheral blood Endocan and Irisin levels has a high value in predicting SF/NR in ACS patients after PCI.

王丽双;郑士玉;娄长芹;姜海岩;王晓艳

132000 吉林省吉林市化工医院心内科132000 吉林,北华大学附属医院心血管内科132000 吉林省吉林市化工医院综合内科132000 吉林省吉林市化工医院心内科132000 吉林省吉林市化工医院心内科

急性冠状动脉综合征经皮冠状动脉介入治疗内皮细胞特异性分子-1鸢尾素慢血流无复流

Acute coronary syndromePercutaneous coronary interventionEndothelial cell specific molecule-1IrisinSlow-flowNo-reflow

《心脑血管病防治》 2026 (1)

23-27,5

10.3969/j.issn.1009-816x.2026.01.005

评论